person

Daniel van Kammen, MD, PhD

as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Study Chair
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
ACADIA Pharmaceuticals Inc.
Roles
Study Chair
Trial investigator
no

Trials led

1
Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
NCT00361166Phase 2Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_CHAIR
Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
trial